ArticleCancers2023

Development of a Patient-Derived 3D Immuno-Oncology Platform to Potentiate Immunotherapy Responses in Ascites-Derived Circulating Tumor Cells.

Thomas J Gerton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.